BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9022297)

  • 1. Metabolism of adenosine and deoxyadenosine by human erythrocytes and CCRF-CEM leukemia cells.
    Szabados E; Duggleby RG; Christopherson RI
    Int J Biochem Cell Biol; 1996 Dec; 28(12):1405-15. PubMed ID: 9022297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid radioassay for metabolites of adenosine and deoxyadenosine in erythrocytes.
    Szabados E; Christopherson RI
    J Chromatogr B Biomed Appl; 1995 Dec; 674(1):132-7. PubMed ID: 8749261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia.
    Kurtzberg J; Hershfield MS
    Cancer Res; 1985 Apr; 45(4):1579-86. PubMed ID: 3872167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of deoxyadenosine plus deoxycoformycin on replicative and repair synthesis of DNA in human lymphoblasts and isolated nuclei.
    Matsumoto SS; Yu J; Yu AL
    J Biol Chem; 1988 May; 263(15):7153-8. PubMed ID: 3259231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purine enzyme profile in human colon-carcinoma cell lines and differential sensitivity to deoxycoformycin and 2'-deoxyadenosine in combination.
    Camici M; Turriani M; Tozzi MG; Turchi G; Cos J; Alemany C; Miralles A; Noe V; Ciudad CJ
    Int J Cancer; 1995 Jul; 62(2):176-83. PubMed ID: 7622293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance of an adenosine kinase-deficient human lymphoblastoid cell line to effects of deoxyadenosine on growth, S-adenosylhomocysteine hydrolase inactivation, and dATP accumulation.
    Hershfield MS; Kredich NM
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4292-6. PubMed ID: 6254019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical correlates of the differential sensitivity of subtypes of human leukemia to deoxyadenosine and deoxycoformycin.
    Matsumoto SS; Yu AL; Bleeker LC; Bakay B; Kung FH; Nyhan WL
    Blood; 1982 Nov; 60(5):1096-102. PubMed ID: 6289941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
    Bontemps F; Van den Berghe G
    Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.
    Bagnara AS; Hershfield MS
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2673-7. PubMed ID: 6283540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential incorporation of 2'-deoxyadenosine into human peripheral lymphocytes.
    Burgess FW; Stoeckler JD; Parks RE
    Biochem Pharmacol; 1985 Sep; 34(18):3353-60. PubMed ID: 3929793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine and deoxyadenosine induces apoptosis in oestrogen receptor-positive and -negative human breast cancer cells via the intrinsic pathway.
    Hashemi M; Karami-Tehrani F; Ghavami S; Maddika S; Los M
    Cell Prolif; 2005 Oct; 38(5):269-85. PubMed ID: 16202036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine-mediated killing of cultured epithelial cancer cells.
    Barry CP; Lind SE
    Cancer Res; 2000 Apr; 60(7):1887-94. PubMed ID: 10766176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the energy metabolism of opossum Didelphis virginiana erythrocytes--IV. Red cells have low adenosine deaminase activity and high levels of deoxyadenosine nucleotides.
    Bethlenfalvay NC; Chadwick E; Lima JE
    Life Sci; 1989; 44(14):963-70. PubMed ID: 2784528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of three T-lymphoid cell lines with distinct sensitivities to deoxyadenosine plus deoxycoformycin.
    Duan DS; Smith W; Sadée W; Cowan MJ
    Thymus; 1992 Feb; 19(1):1-11. PubMed ID: 1373528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine analogs as possible differentiation-inducing agents against acute myeloid leukemia.
    Niitsu N; Honma Y
    Leuk Lymphoma; 1999 Jul; 34(3-4):261-71. PubMed ID: 10439363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terminal incorporation of 2'-deoxyadenosine into polyadenylate segments of polyadenylated RNA in G1-phase-arrested human T-lymphoblasts.
    Kefford RF; Fox RM; McCairns E; Fahey D; Muscat GE; Rowe PB
    Cancer Res; 1983 May; 43(5):2252-7. PubMed ID: 6187447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2'-deoxyadenosine induces apoptosis in rat chromaffin cells.
    Wakade AR; Guo X; Palmer KC; Kulkarni JS; Przywara DA; Wakade TD
    J Neurochem; 1996 Dec; 67(6):2273-81. PubMed ID: 8931458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
    Yu AL; Bakay B; Kung FH; Nyhan WL
    Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal handling of 2'-deoxyadenosine and adenosine in humans and mice.
    Kuttesch JF; Nelson JA
    Cancer Chemother Pharmacol; 1982; 8(2):221-9. PubMed ID: 6980741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human melanoma cells sensitive to deoxyadenosine and deoxyinosine.
    Parsons PG; Hayward IP
    Biochem Pharmacol; 1986 Feb; 35(4):655-60. PubMed ID: 3004507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.